NCT05150561Active, not recruiting
Muscle Dysfunction in Patients With Haematological Diseases
The Prevalence and the Prognostic Value of Sarcopenia Among Patients With Haematological Cancer Diseases - A Prospective Observational Cohort Study.
Source: ClinicalTrials.gov · Last updated 14 Aug 2026
Brief summary (registry, in English)
PURPOSE: To evaluate the prevalence and prognostic value of sarcopenia in patients diagnosed with hematological cancer diseases.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 216 (estimated)
- First submitted
- 8 Nov 2021
- Start date
- Oct 2023
- Primary completion date
- Oct 2026
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- NCT number
- NCT05150561
What you commit to
- Study type: Observational
- Planned participants: 216
- From Oct 2023 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age: \<18
Other
- Pregnancy
- Physical or mental disabilities precluding test of muscle function
- Inability to read and understand Danish.
Who the study is looking for
- Patients diagnosed with malignant lymphomas, acute leukaemia and multiple myeloma referred to treatment at the Department of Haematology, Rigshospitalet.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.